

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.57382679 |
| 2 | DNA strand elongation (GO:0022616) | 5.24244552 |
| 3 | DNA unwinding involved in DNA replication (GO:0006268) | 5.24068419 |
| 4 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.21877814 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.04343045 |
| 6 | DNA replication initiation (GO:0006270) | 4.77958862 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.68817986 |
| 8 | formation of translation preinitiation complex (GO:0001731) | 4.64193122 |
| 9 | DNA deamination (GO:0045006) | 4.48324689 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.47475806 |
| 11 | telomere maintenance via recombination (GO:0000722) | 4.37422420 |
| 12 | nucleobase biosynthetic process (GO:0046112) | 4.27310420 |
| 13 | IMP biosynthetic process (GO:0006188) | 4.26997910 |
| 14 | response to peptidoglycan (GO:0032494) | 4.23383725 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.21486997 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19496772 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.10567554 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 3.99139800 |
| 19 | mitotic recombination (GO:0006312) | 3.98968831 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.93487418 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.93487418 |
| 22 | detection of bacterium (GO:0016045) | 3.92906630 |
| 23 | IMP metabolic process (GO:0046040) | 3.91483818 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90805670 |
| 25 | regulation of translational fidelity (GO:0006450) | 3.89495035 |
| 26 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.85834146 |
| 27 | protein localization to kinetochore (GO:0034501) | 3.81116564 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.80718872 |
| 29 | detection of other organism (GO:0098543) | 3.80411373 |
| 30 | purine nucleobase biosynthetic process (GO:0009113) | 3.78396769 |
| 31 | telomere maintenance via telomere lengthening (GO:0010833) | 3.73507190 |
| 32 | viral transcription (GO:0019083) | 3.72704698 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70020729 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70020729 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.70020729 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70020729 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.70020729 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70020729 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.65392984 |
| 40 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.65099267 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63989939 |
| 42 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.63543093 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59663495 |
| 44 | translational termination (GO:0006415) | 3.59460846 |
| 45 | purine nucleotide salvage (GO:0032261) | 3.59433535 |
| 46 | translational elongation (GO:0006414) | 3.57171728 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.55680155 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.53468680 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.51432853 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50366253 |
| 51 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.49680466 |
| 52 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.41955993 |
| 53 | leukocyte aggregation (GO:0070486) | 3.38118752 |
| 54 | pentose-phosphate shunt (GO:0006098) | 3.36054678 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27485184 |
| 56 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.27435474 |
| 57 | translational initiation (GO:0006413) | 3.27250050 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.26866802 |
| 59 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.26516177 |
| 60 | Peyers patch development (GO:0048541) | 3.26516177 |
| 61 | mitotic nuclear envelope disassembly (GO:0007077) | 3.24234277 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23302365 |
| 63 | regulation of protein heterodimerization activity (GO:0043497) | 3.21784727 |
| 64 | DNA duplex unwinding (GO:0032508) | 3.21570136 |
| 65 | regulation of superoxide anion generation (GO:0032928) | 3.21365118 |
| 66 | DNA geometric change (GO:0032392) | 3.20680457 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 3.16333185 |
| 68 | viral mRNA export from host cell nucleus (GO:0046784) | 3.15456447 |
| 69 | negative regulation of RNA splicing (GO:0033119) | 3.14820336 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14510244 |
| 71 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.09975251 |
| 72 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.07710341 |
| 73 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.07710341 |
| 74 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.05541649 |
| 75 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.05329233 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.04796755 |
| 77 | pinocytosis (GO:0006907) | 3.01970859 |
| 78 | ribosomal small subunit biogenesis (GO:0042274) | 3.01372978 |
| 79 | thymic T cell selection (GO:0045061) | 3.01197202 |
| 80 | base-excision repair (GO:0006284) | 3.00110110 |
| 81 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.99271434 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 2.98692188 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 2.98123024 |
| 84 | viral life cycle (GO:0019058) | 2.97947158 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.97598231 |
| 86 | nuclear envelope disassembly (GO:0051081) | 2.97555225 |
| 87 | membrane disassembly (GO:0030397) | 2.97555225 |
| 88 | spliceosomal snRNP assembly (GO:0000387) | 2.97121770 |
| 89 | nucleotide salvage (GO:0043173) | 2.96380697 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.96367432 |
| 91 | mitochondrial RNA metabolic process (GO:0000959) | 2.94852166 |
| 92 | ribosome biogenesis (GO:0042254) | 2.93196235 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.91487200 |
| 94 | mitotic sister chromatid segregation (GO:0000070) | 2.91269203 |
| 95 | cotranslational protein targeting to membrane (GO:0006613) | 2.89470727 |
| 96 | NADPH regeneration (GO:0006740) | 2.89093349 |
| 97 | DNA replication checkpoint (GO:0000076) | 2.89019121 |
| 98 | protein targeting to ER (GO:0045047) | 2.88212285 |
| 99 | negative regulation of necroptotic process (GO:0060546) | 2.87052646 |
| 100 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.85871558 |
| 101 | cell cycle G1/S phase transition (GO:0044843) | 2.85871558 |
| 102 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.84921593 |
| 103 | neutrophil activation (GO:0042119) | 2.84284764 |
| 104 | tRNA aminoacylation for protein translation (GO:0006418) | 2.83953764 |
| 105 | cellular protein complex disassembly (GO:0043624) | 2.83528868 |
| 106 | ncRNA 3-end processing (GO:0043628) | 2.83447483 |
| 107 | protein localization to chromosome, centromeric region (GO:0071459) | 2.82483952 |
| 108 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.81892042 |
| 109 | response to host immune response (GO:0052572) | 2.81262926 |
| 110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81262926 |
| 111 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81120104 |
| 112 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80928791 |
| 113 | rRNA processing (GO:0006364) | 2.80558095 |
| 114 | T cell selection (GO:0045058) | 2.80367504 |
| 115 | tRNA aminoacylation (GO:0043039) | 2.80364134 |
| 116 | amino acid activation (GO:0043038) | 2.80364134 |
| 117 | negative regulation of mRNA processing (GO:0050686) | 2.80142197 |
| 118 | L-serine metabolic process (GO:0006563) | 2.79849575 |
| 119 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.79489912 |
| 120 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.79474445 |
| 121 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.79474445 |
| 122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78230841 |
| 123 | purine-containing compound salvage (GO:0043101) | 2.77960543 |
| 124 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77837827 |
| 125 | negative T cell selection (GO:0043383) | 2.77587689 |
| 126 | respiratory burst (GO:0045730) | 2.77205848 |
| 127 | detection of external biotic stimulus (GO:0098581) | 2.76485974 |
| 128 | regulation of leukocyte degranulation (GO:0043300) | 2.76227040 |
| 129 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.75707384 |
| 130 | folic acid metabolic process (GO:0046655) | 2.75120307 |
| 131 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.75006327 |
| 132 | mRNA splicing, via spliceosome (GO:0000398) | 2.75006327 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.74765976 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.74198000 |
| 135 | cellular response to type I interferon (GO:0071357) | 2.74198000 |
| 136 | B cell mediated immunity (GO:0019724) | 2.72843762 |
| 137 | telomere organization (GO:0032200) | 2.72798118 |
| 138 | histone H2A acetylation (GO:0043968) | 2.72198987 |
| 139 | protein localization to endoplasmic reticulum (GO:0070972) | 2.71654824 |
| 140 | RNA splicing, via transesterification reactions (GO:0000375) | 2.71167838 |
| 141 | response to type I interferon (GO:0034340) | 2.70365138 |
| 142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.70118111 |
| 143 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.69723153 |
| 144 | granulocyte activation (GO:0036230) | 2.69618190 |
| 145 | mature B cell differentiation involved in immune response (GO:0002313) | 2.69257359 |
| 146 | telomere maintenance (GO:0000723) | 2.69031915 |
| 147 | translesion synthesis (GO:0019985) | 2.68830220 |
| 148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68758228 |
| 149 | rRNA metabolic process (GO:0016072) | 2.68283811 |
| 150 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.68161433 |
| 151 | positive regulation of antigen processing and presentation (GO:0002579) | 2.68114555 |
| 152 | negative regulation of histone acetylation (GO:0035067) | 2.68042279 |
| 153 | protein complex disassembly (GO:0043241) | 2.66442072 |
| 154 | response to host (GO:0075136) | 2.65901118 |
| 155 | response to host defenses (GO:0052200) | 2.65901118 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65901118 |
| 157 | negative regulation of ligase activity (GO:0051352) | 2.63185558 |
| 158 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.63185558 |
| 159 | mitotic chromosome condensation (GO:0007076) | 2.62690187 |
| 160 | negative regulation of innate immune response (GO:0045824) | 2.62411099 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62286733 |
| 162 | mitotic G1/S transition checkpoint (GO:0044819) | 2.62132537 |
| 163 | regulation of necroptotic process (GO:0060544) | 2.61524744 |
| 164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.61128628 |
| 165 | regulation of necrotic cell death (GO:0010939) | 2.60133894 |
| 166 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.59590514 |
| 167 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.59292527 |
| 168 | histone arginine methylation (GO:0034969) | 2.59279476 |
| 169 | G1 DNA damage checkpoint (GO:0044783) | 2.58820057 |
| 170 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.57955047 |
| 171 | establishment of integrated proviral latency (GO:0075713) | 2.57216016 |
| 172 | detection of biotic stimulus (GO:0009595) | 2.56815245 |
| 173 | postreplication repair (GO:0006301) | 2.56268475 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56129759 |
| 175 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.55080718 |
| 176 | natural killer cell differentiation (GO:0001779) | 2.54950017 |
| 177 | sulfur amino acid catabolic process (GO:0000098) | 2.54372553 |
| 178 | mannose metabolic process (GO:0006013) | 2.53455303 |
| 179 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52280402 |
| 180 | modulation by virus of host process (GO:0019054) | 2.52150024 |
| 181 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52051294 |
| 182 | regulation of T cell tolerance induction (GO:0002664) | 2.51483289 |
| 183 | glycosphingolipid catabolic process (GO:0046479) | 2.51183448 |
| 184 | T cell migration (GO:0072678) | 2.50592526 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50526792 |
| 186 | negative regulation of B cell apoptotic process (GO:0002903) | 2.50438077 |
| 187 | negative regulation of phagocytosis (GO:0050765) | 2.48310828 |
| 188 | cellular response to interleukin-4 (GO:0071353) | 2.46635125 |
| 189 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45856005 |
| 190 | amino sugar catabolic process (GO:0046348) | 2.45637654 |
| 191 | positive T cell selection (GO:0043368) | 2.45615924 |
| 192 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43859899 |
| 193 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43000880 |
| 194 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.42509328 |
| 195 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42458394 |
| 196 | response to thyroid hormone (GO:0097066) | 2.42252070 |
| 197 | myeloid dendritic cell activation (GO:0001773) | 2.40173265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.31082944 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.30582298 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58481207 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.75824204 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.74193563 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67519966 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64442956 |
| 8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.54885354 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.52219543 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.48271165 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43582099 |
| 12 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.37210833 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.36625493 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34098802 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33762065 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.33359374 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.32429735 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15064408 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14062339 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.10059199 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.09689594 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02270929 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00087481 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98574968 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.98481760 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96899329 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96744366 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95243326 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.91240958 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81506822 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.79008734 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78184096 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77329682 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71254899 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71203513 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.70461239 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69509225 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68675345 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66568046 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64340694 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61600940 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61090427 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61080540 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60836785 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59483473 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59400452 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.57467262 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56335481 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56185648 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55945124 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54249798 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53795293 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.52135644 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51501364 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50992327 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48199155 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.47658003 |
| 58 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46933353 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45524833 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45389479 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45045541 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44900669 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43384428 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.43268127 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42545810 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42048879 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39286302 |
| 68 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39168072 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38616182 |
| 70 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38392483 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38045398 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37786552 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.37321946 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36991230 |
| 75 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.36975101 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36621175 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35874288 |
| 78 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35383166 |
| 79 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30447663 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30062261 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29857690 |
| 82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29549444 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.29053837 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25762781 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24558438 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24160706 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24077975 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23198822 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22704335 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22447691 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21919422 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20411947 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20260864 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20162672 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20141909 |
| 96 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19307385 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 1.18967577 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18641095 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.18139537 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17655894 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15781757 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15291569 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15014574 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13692205 |
| 105 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12156434 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11546301 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11417101 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.11117064 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10973694 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10858116 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10766282 |
| 112 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09611374 |
| 113 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09524841 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08406196 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08099337 |
| 116 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07064247 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06999230 |
| 118 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06903748 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05834320 |
| 120 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05737286 |
| 121 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05703692 |
| 122 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04212901 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04209047 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03319989 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03288247 |
| 126 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03045953 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03014079 |
| 128 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02686273 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02548060 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01706498 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01596915 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01136761 |
| 133 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00965479 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00751024 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98278335 |
| 136 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97982524 |
| 137 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97711166 |
| 138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95696616 |
| 139 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95410383 |
| 140 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95239999 |
| 141 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94296234 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93260830 |
| 143 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92894338 |
| 144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92022918 |
| 145 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91040108 |
| 146 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89562497 |
| 147 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88340657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.95272076 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.72027130 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.66524896 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.43372735 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.40610707 |
| 6 | MP0003077_abnormal_cell_cycle | 3.22254291 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.97277102 |
| 8 | MP0008057_abnormal_DNA_replication | 2.85572241 |
| 9 | MP0005451_abnormal_body_composition | 2.69321716 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.69129812 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.65224462 |
| 12 | MP0003724_increased_susceptibility_to | 2.65017307 |
| 13 | MP0008058_abnormal_DNA_repair | 2.33020668 |
| 14 | MP0008260_abnormal_autophagy | 2.31880280 |
| 15 | MP0005387_immune_system_phenotype | 2.26064163 |
| 16 | MP0001790_abnormal_immune_system | 2.26064163 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.22105529 |
| 18 | MP0000490_abnormal_crypts_of | 2.19599892 |
| 19 | MP0002132_abnormal_respiratory_system | 2.12831467 |
| 20 | MP0003303_peritoneal_inflammation | 2.12648427 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.11219654 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 2.07290876 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.02458575 |
| 24 | MP0001545_abnormal_hematopoietic_system | 2.02458575 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.99266705 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.97313971 |
| 27 | MP0003436_decreased_susceptibility_to | 1.96098848 |
| 28 | MP0001730_embryonic_growth_arrest | 1.95494505 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.93014372 |
| 30 | MP0006082_CNS_inflammation | 1.88422703 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.85603646 |
| 32 | MP0002398_abnormal_bone_marrow | 1.83227885 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.82487773 |
| 34 | MP0008932_abnormal_embryonic_tissue | 1.80838274 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.80109152 |
| 36 | MP0002722_abnormal_immune_system | 1.76659817 |
| 37 | MP0010307_abnormal_tumor_latency | 1.71618970 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.65595617 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.64733564 |
| 40 | MP0004947_skin_inflammation | 1.64028240 |
| 41 | MP0003123_paternal_imprinting | 1.63152799 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.59427036 |
| 43 | MP0002019_abnormal_tumor_incidence | 1.59411551 |
| 44 | MP0002429_abnormal_blood_cell | 1.53830426 |
| 45 | MP0000313_abnormal_cell_death | 1.53249870 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.52725074 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.52146679 |
| 48 | MP0009278_abnormal_bone_marrow | 1.49389757 |
| 49 | MP0002080_prenatal_lethality | 1.43821203 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.43419644 |
| 51 | MP0001853_heart_inflammation | 1.42288700 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.41901791 |
| 53 | MP0001800_abnormal_humoral_immune | 1.40505684 |
| 54 | MP0000716_abnormal_immune_system | 1.39793311 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.38957937 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.37943626 |
| 57 | MP0000358_abnormal_cell_content/ | 1.36696810 |
| 58 | MP0001819_abnormal_immune_cell | 1.36695656 |
| 59 | MP0001697_abnormal_embryo_size | 1.34992584 |
| 60 | MP0005360_urolithiasis | 1.34899556 |
| 61 | MP0003075_altered_response_to | 1.33983358 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.33013241 |
| 63 | MP0002419_abnormal_innate_immunity | 1.32632253 |
| 64 | MP0000685_abnormal_immune_system | 1.30526972 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.28760826 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.26236011 |
| 67 | MP0005025_abnormal_response_to | 1.22852263 |
| 68 | MP0002723_abnormal_immune_serum | 1.22013515 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 1.19092361 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.18598060 |
| 71 | MP0003984_embryonic_growth_retardation | 1.18360361 |
| 72 | MP0005380_embryogenesis_phenotype | 1.18049946 |
| 73 | MP0001672_abnormal_embryogenesis/_devel | 1.18049946 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 1.16170995 |
| 75 | MP0004147_increased_porphyrin_level | 1.15146425 |
| 76 | MP0009840_abnormal_foam_cell | 1.15044125 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.14637723 |
| 78 | MP0002405_respiratory_system_inflammati | 1.14626036 |
| 79 | MP0005670_abnormal_white_adipose | 1.11754891 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.10327060 |
| 81 | MP0004133_heterotaxia | 1.10280072 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 1.09172188 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.08885816 |
| 84 | MP0002086_abnormal_extraembryonic_tissu | 1.08643479 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.07102807 |
| 86 | MP0003186_abnormal_redox_activity | 1.06712037 |
| 87 | MP0003786_premature_aging | 1.03123979 |
| 88 | MP0005166_decreased_susceptibility_to | 1.02057217 |
| 89 | MP0003866_abnormal_defecation | 1.00550122 |
| 90 | MP0005384_cellular_phenotype | 1.00317720 |
| 91 | MP0001851_eye_inflammation | 0.98451071 |
| 92 | MP0000343_altered_response_to | 0.97515967 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.96546958 |
| 94 | MP0001873_stomach_inflammation | 0.95763098 |
| 95 | MP0005621_abnormal_cell_physiology | 0.95666772 |
| 96 | MP0005266_abnormal_metabolism | 0.95515195 |
| 97 | MP0001849_ear_inflammation | 0.94645068 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.94627719 |
| 99 | MP0009764_decreased_sensitivity_to | 0.94218006 |
| 100 | MP0002269_muscular_atrophy | 0.93470411 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.92162113 |
| 102 | MP0008995_early_reproductive_senescence | 0.91657117 |
| 103 | MP0005310_abnormal_salivary_gland | 0.91272949 |
| 104 | MP0000604_amyloidosis | 0.90961870 |
| 105 | MP0000598_abnormal_liver_morphology | 0.90433744 |
| 106 | MP0004197_abnormal_fetal_growth/weight/ | 0.90413375 |
| 107 | MP0000858_altered_metastatic_potential | 0.89379194 |
| 108 | MP0000371_diluted_coat_color | 0.89290824 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.87359561 |
| 110 | MP0002085_abnormal_embryonic_tissue | 0.87324179 |
| 111 | MP0005671_abnormal_response_to | 0.86875668 |
| 112 | MP0002084_abnormal_developmental_patter | 0.86476587 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.86366422 |
| 114 | MP0008873_increased_physiological_sensi | 0.86064711 |
| 115 | MP0009785_altered_susceptibility_to | 0.85915365 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.85637253 |
| 117 | MP0000681_abnormal_thyroid_gland | 0.85081859 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.83801076 |
| 119 | MP0004510_myositis | 0.82789683 |
| 120 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81389329 |
| 121 | MP0005023_abnormal_wound_healing | 0.80105056 |
| 122 | MP0006054_spinal_hemorrhage | 0.79691139 |
| 123 | MP0008770_decreased_survivor_rate | 0.78052300 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.76787498 |
| 125 | MP0003828_pulmonary_edema | 0.76603994 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.76343015 |
| 127 | MP0003121_genomic_imprinting | 0.76285815 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.76175015 |
| 129 | MP0008469_abnormal_protein_level | 0.76015521 |
| 130 | MP0001915_intracranial_hemorrhage | 0.75650473 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.74072809 |
| 132 | MP0009763_increased_sensitivity_to | 0.73728119 |
| 133 | MP0001661_extended_life_span | 0.73336130 |
| 134 | MP0005390_skeleton_phenotype | 0.71815029 |
| 135 | MP0000747_muscle_weakness | 0.71197556 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71017156 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.70536966 |
| 138 | MP0001764_abnormal_homeostasis | 0.68315786 |
| 139 | MP0001663_abnormal_digestive_system | 0.67825432 |
| 140 | MP0003795_abnormal_bone_structure | 0.67492169 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.65939039 |
| 142 | MP0009931_abnormal_skin_appearance | 0.65802555 |
| 143 | MP0008874_decreased_physiological_sensi | 0.64319729 |
| 144 | MP0002277_abnormal_respiratory_mucosa | 0.64148429 |
| 145 | MP0003448_altered_tumor_morphology | 0.63764371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.02252195 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.98593748 |
| 3 | Reticulocytopenia (HP:0001896) | 3.75643558 |
| 4 | Agnosia (HP:0010524) | 3.73063449 |
| 5 | Thrombocytosis (HP:0001894) | 3.69889082 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 3.66660996 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.62501135 |
| 8 | Obstructive lung disease (HP:0006536) | 3.62501135 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.60993742 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.58432985 |
| 11 | Myositis (HP:0100614) | 3.39370442 |
| 12 | Birth length less than 3rd percentile (HP:0003561) | 3.39032086 |
| 13 | Hypertensive crisis (HP:0100735) | 3.24338999 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.23679339 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.23679339 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.23679339 |
| 17 | Ependymoma (HP:0002888) | 3.06629184 |
| 18 | Meningitis (HP:0001287) | 3.03671112 |
| 19 | Fatigue (HP:0012378) | 2.93500352 |
| 20 | Urticaria (HP:0001025) | 2.91993367 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88613848 |
| 22 | Recurrent skin infections (HP:0001581) | 2.88459423 |
| 23 | Loss of speech (HP:0002371) | 2.85956588 |
| 24 | Agammaglobulinemia (HP:0004432) | 2.82470428 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.80788394 |
| 26 | Increased IgE level (HP:0003212) | 2.79602832 |
| 27 | Petechiae (HP:0000967) | 2.76183281 |
| 28 | IgM deficiency (HP:0002850) | 2.75742184 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73218376 |
| 30 | Multiple enchondromatosis (HP:0005701) | 2.64947596 |
| 31 | Colitis (HP:0002583) | 2.63919355 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.63089347 |
| 33 | Pallor (HP:0000980) | 2.61528473 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.61000278 |
| 35 | Granulocytopenia (HP:0001913) | 2.59622541 |
| 36 | Purpura (HP:0000979) | 2.59398834 |
| 37 | Cholecystitis (HP:0001082) | 2.58262377 |
| 38 | Abnormal gallbladder physiology (HP:0012438) | 2.58262377 |
| 39 | Anorexia (HP:0002039) | 2.56688779 |
| 40 | Polygenic inheritance (HP:0010982) | 2.56311842 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.56230034 |
| 42 | Basal cell carcinoma (HP:0002671) | 2.55019909 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54984597 |
| 44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.52179547 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.50314029 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.49477544 |
| 47 | Abnormality of reticulocytes (HP:0004312) | 2.47694646 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.47354339 |
| 49 | Pustule (HP:0200039) | 2.47328204 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.47066680 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.46969300 |
| 52 | Increased IgM level (HP:0003496) | 2.45505297 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.44589082 |
| 54 | Medulloblastoma (HP:0002885) | 2.44568325 |
| 55 | Aplastic anemia (HP:0001915) | 2.43880606 |
| 56 | Epistaxis (HP:0000421) | 2.39735310 |
| 57 | Selective tooth agenesis (HP:0001592) | 2.38973074 |
| 58 | Oral leukoplakia (HP:0002745) | 2.37818771 |
| 59 | Degeneration of anterior horn cells (HP:0002398) | 2.37470392 |
| 60 | Abnormality of the anterior horn cell (HP:0006802) | 2.37470392 |
| 61 | Colon cancer (HP:0003003) | 2.35624185 |
| 62 | Macrocytic anemia (HP:0001972) | 2.35241356 |
| 63 | Spastic diplegia (HP:0001264) | 2.32624215 |
| 64 | Myopathic facies (HP:0002058) | 2.31440600 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.30985652 |
| 66 | Poikiloderma (HP:0001029) | 2.30340242 |
| 67 | Stomatitis (HP:0010280) | 2.28224431 |
| 68 | Dysostosis multiplex (HP:0000943) | 2.28135755 |
| 69 | Myocardial infarction (HP:0001658) | 2.27903497 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25727748 |
| 71 | Orchitis (HP:0100796) | 2.25678712 |
| 72 | Gastrointestinal dysmotility (HP:0002579) | 2.25425488 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 2.25173430 |
| 74 | Rough bone trabeculation (HP:0100670) | 2.24703060 |
| 75 | Vasculitis (HP:0002633) | 2.23998105 |
| 76 | Microretrognathia (HP:0000308) | 2.23212148 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21161591 |
| 78 | Personality changes (HP:0000751) | 2.20821261 |
| 79 | Cutaneous melanoma (HP:0012056) | 2.20723826 |
| 80 | Recurrent viral infections (HP:0004429) | 2.19895642 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19286749 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19286749 |
| 83 | Encephalitis (HP:0002383) | 2.15788593 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.15226106 |
| 85 | Slow saccadic eye movements (HP:0000514) | 2.12530591 |
| 86 | Abnormal platelet function (HP:0011869) | 2.11581128 |
| 87 | Impaired platelet aggregation (HP:0003540) | 2.11581128 |
| 88 | Abnormality of glycolysis (HP:0004366) | 2.11338605 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.11338605 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.10449675 |
| 91 | Poor head control (HP:0002421) | 2.09631022 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09386233 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.09386233 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08966824 |
| 95 | Bone marrow hypocellularity (HP:0005528) | 2.08550257 |
| 96 | Cellular immunodeficiency (HP:0005374) | 2.08053048 |
| 97 | Myelodysplasia (HP:0002863) | 2.07143886 |
| 98 | Arterial thrombosis (HP:0004420) | 2.04738710 |
| 99 | Megaloblastic anemia (HP:0001889) | 2.04496795 |
| 100 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04461968 |
| 101 | Pancytopenia (HP:0001876) | 2.04149819 |
| 102 | Chest pain (HP:0100749) | 2.04090800 |
| 103 | Squamous cell carcinoma (HP:0002860) | 2.03559657 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.02918555 |
| 105 | Esophageal varix (HP:0002040) | 2.01738733 |
| 106 | Sepsis (HP:0100806) | 2.01348621 |
| 107 | Pulmonary embolism (HP:0002204) | 2.01015074 |
| 108 | Esophageal neoplasm (HP:0100751) | 2.00723315 |
| 109 | Neoplasm of head and neck (HP:0012288) | 2.00723315 |
| 110 | Astrocytoma (HP:0009592) | 2.00338483 |
| 111 | Abnormality of the astrocytes (HP:0100707) | 2.00338483 |
| 112 | Amyloidosis (HP:0011034) | 2.00002870 |
| 113 | Seborrheic dermatitis (HP:0001051) | 1.99801088 |
| 114 | Prolonged bleeding time (HP:0003010) | 1.99712235 |
| 115 | Gastrointestinal stroma tumor (HP:0100723) | 1.98602730 |
| 116 | Increased density of long bones (HP:0006392) | 1.98326403 |
| 117 | Vertebral compression fractures (HP:0002953) | 1.97502516 |
| 118 | Ragged-red muscle fibers (HP:0003200) | 1.97092064 |
| 119 | Abnormality of the motor neurons (HP:0002450) | 1.96740558 |
| 120 | Abnormal neuron morphology (HP:0012757) | 1.96740558 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 1.96637225 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.95607027 |
| 123 | Hypokinesia (HP:0002375) | 1.95333692 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 1.94901110 |
| 125 | Proximal placement of thumb (HP:0009623) | 1.94492065 |
| 126 | Neurodegeneration (HP:0002180) | 1.94139175 |
| 127 | Acute lymphatic leukemia (HP:0006721) | 1.92604620 |
| 128 | Abnormality of the thoracic spine (HP:0100711) | 1.92119227 |
| 129 | Hemoptysis (HP:0002105) | 1.92016188 |
| 130 | Gingivitis (HP:0000230) | 1.91883356 |
| 131 | Lymphopenia (HP:0001888) | 1.91328240 |
| 132 | Optic neuritis (HP:0100653) | 1.91279862 |
| 133 | Retrobulbar optic neuritis (HP:0100654) | 1.91279862 |
| 134 | Ileus (HP:0002595) | 1.90543057 |
| 135 | Chronic otitis media (HP:0000389) | 1.90292087 |
| 136 | Adenoma sebaceum (HP:0009720) | 1.90273429 |
| 137 | Angiofibromas (HP:0010615) | 1.90273429 |
| 138 | Cellulitis (HP:0100658) | 1.89886217 |
| 139 | Increased serum lactate (HP:0002151) | 1.88469852 |
| 140 | Premature graying of hair (HP:0002216) | 1.88343355 |
| 141 | Breast hypoplasia (HP:0003187) | 1.88118216 |
| 142 | Verrucae (HP:0200043) | 1.88102805 |
| 143 | Papilloma (HP:0012740) | 1.88102805 |
| 144 | Reduced antithrombin III activity (HP:0001976) | 1.88057706 |
| 145 | Hypertriglyceridemia (HP:0002155) | 1.87940485 |
| 146 | Gingival bleeding (HP:0000225) | 1.87634222 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.87512499 |
| 148 | Type I transferrin isoform profile (HP:0003642) | 1.86525003 |
| 149 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84784426 |
| 150 | Mediastinal lymphadenopathy (HP:0100721) | 1.83963201 |
| 151 | Slender long bone (HP:0003100) | 1.83825379 |
| 152 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81509470 |
| 153 | Deviation of the thumb (HP:0009603) | 1.80654160 |
| 154 | Increased serum ferritin (HP:0003281) | 1.80086383 |
| 155 | Spinal muscular atrophy (HP:0007269) | 1.79663714 |
| 156 | Prolonged neonatal jaundice (HP:0006579) | 1.79487362 |
| 157 | Upper motor neuron abnormality (HP:0002127) | 1.77626348 |
| 158 | Distal lower limb muscle weakness (HP:0009053) | 1.77427814 |
| 159 | Pulmonary infiltrates (HP:0002113) | 1.77137016 |
| 160 | Reticulocytosis (HP:0001923) | 1.75723383 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75042544 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75042544 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75042544 |
| 164 | Osteomyelitis (HP:0002754) | 1.74754745 |
| 165 | Abnormality of T cells (HP:0002843) | 1.74663658 |
| 166 | Diminished motivation (HP:0000745) | 1.73254162 |
| 167 | Skin ulcer (HP:0200042) | 1.73108848 |
| 168 | Emotional lability (HP:0000712) | 1.72966060 |
| 169 | Opisthotonus (HP:0002179) | 1.72575103 |
| 170 | Hyperacusis (HP:0010780) | 1.72196823 |
| 171 | Neoplasm of the pancreas (HP:0002894) | 1.72039799 |
| 172 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.71242244 |
| 173 | Hypermelanotic macule (HP:0001034) | 1.69447694 |
| 174 | Joint stiffness (HP:0001387) | 1.69062479 |
| 175 | High pitched voice (HP:0001620) | 1.68854115 |
| 176 | Lymphoma (HP:0002665) | 1.67826258 |
| 177 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.65821947 |
| 178 | Severe visual impairment (HP:0001141) | 1.65732197 |
| 179 | Postnatal microcephaly (HP:0005484) | 1.65415400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.27887145 |
| 2 | EEF2K | 3.16053271 |
| 3 | SMG1 | 3.01336885 |
| 4 | WEE1 | 2.77224462 |
| 5 | PRPF4B | 2.76802152 |
| 6 | RIPK4 | 2.70553559 |
| 7 | SCYL2 | 2.61070471 |
| 8 | NEK1 | 2.45596431 |
| 9 | MAP3K3 | 2.41534146 |
| 10 | CDC7 | 2.37894017 |
| 11 | IRAK3 | 2.29212252 |
| 12 | MAP4K1 | 2.23114583 |
| 13 | EIF2AK1 | 2.22982169 |
| 14 | TSSK6 | 2.12546688 |
| 15 | NME2 | 2.00077336 |
| 16 | PKN2 | 1.93737966 |
| 17 | NEK2 | 1.93104373 |
| 18 | JAK3 | 1.89485429 |
| 19 | MAP3K11 | 1.85154974 |
| 20 | KIT | 1.85061643 |
| 21 | TRIB3 | 1.82677361 |
| 22 | STK16 | 1.81304496 |
| 23 | GRK6 | 1.73249957 |
| 24 | BCKDK | 1.70570372 |
| 25 | TGFBR1 | 1.69397198 |
| 26 | DAPK1 | 1.68678584 |
| 27 | PAK4 | 1.67243186 |
| 28 | VRK1 | 1.59222119 |
| 29 | EIF2AK3 | 1.57365914 |
| 30 | ACVR1B | 1.48997529 |
| 31 | RPS6KB2 | 1.48947185 |
| 32 | TESK1 | 1.47486945 |
| 33 | ERN1 | 1.46835967 |
| 34 | SIK2 | 1.43390603 |
| 35 | TNK2 | 1.43046288 |
| 36 | CCNB1 | 1.41354879 |
| 37 | CDK7 | 1.41022430 |
| 38 | CSF1R | 1.40558857 |
| 39 | MAP3K10 | 1.37912222 |
| 40 | SIK1 | 1.37490296 |
| 41 | CDK8 | 1.36997319 |
| 42 | VRK2 | 1.28226463 |
| 43 | TESK2 | 1.28110489 |
| 44 | ICK | 1.27456787 |
| 45 | RPS6KA4 | 1.27201211 |
| 46 | PIM2 | 1.27143832 |
| 47 | FES | 1.27010993 |
| 48 | MAP3K14 | 1.26973651 |
| 49 | CSK | 1.24097064 |
| 50 | MAP2K3 | 1.23896752 |
| 51 | BLK | 1.22804343 |
| 52 | FGR | 1.22502593 |
| 53 | ATR | 1.21827843 |
| 54 | DYRK3 | 1.21265838 |
| 55 | CDK9 | 1.20045657 |
| 56 | IRAK2 | 1.17964287 |
| 57 | FLT3 | 1.17875647 |
| 58 | ZAP70 | 1.16465844 |
| 59 | PLK1 | 1.12812094 |
| 60 | MAP3K13 | 1.12127773 |
| 61 | MAP3K8 | 1.11720247 |
| 62 | BTK | 1.10994383 |
| 63 | IKBKE | 1.07737574 |
| 64 | MATK | 1.07725156 |
| 65 | TYK2 | 1.06892475 |
| 66 | PASK | 1.02856382 |
| 67 | ARAF | 0.98607818 |
| 68 | MAP3K12 | 0.98019315 |
| 69 | STK10 | 0.96850899 |
| 70 | IKBKB | 0.93654342 |
| 71 | STK4 | 0.91629822 |
| 72 | TTK | 0.91614094 |
| 73 | MAPKAPK3 | 0.91394499 |
| 74 | TAOK2 | 0.89111126 |
| 75 | PTK6 | 0.88917481 |
| 76 | MAP3K1 | 0.87638849 |
| 77 | CDK19 | 0.86650447 |
| 78 | SYK | 0.85711764 |
| 79 | CDK4 | 0.85710317 |
| 80 | PIM1 | 0.85080950 |
| 81 | PRKD2 | 0.84777677 |
| 82 | CAMKK2 | 0.84701568 |
| 83 | AURKB | 0.83921140 |
| 84 | TBK1 | 0.82895154 |
| 85 | YES1 | 0.81717903 |
| 86 | MAP3K6 | 0.80480381 |
| 87 | TTN | 0.79957805 |
| 88 | BRSK2 | 0.79400999 |
| 89 | RPS6KA6 | 0.76832852 |
| 90 | LRRK2 | 0.75972943 |
| 91 | RPS6KL1 | 0.75176362 |
| 92 | RPS6KC1 | 0.75176362 |
| 93 | BRSK1 | 0.72877293 |
| 94 | TAOK1 | 0.72038730 |
| 95 | JAK2 | 0.71804534 |
| 96 | CHEK1 | 0.71705048 |
| 97 | KDR | 0.69643613 |
| 98 | CHEK2 | 0.69430506 |
| 99 | ALK | 0.66153466 |
| 100 | CDK12 | 0.64331494 |
| 101 | TEC | 0.63674632 |
| 102 | TLK1 | 0.62505991 |
| 103 | EPHB1 | 0.62385127 |
| 104 | ITK | 0.62340762 |
| 105 | MAPKAPK2 | 0.59420501 |
| 106 | LYN | 0.58947315 |
| 107 | TGFBR2 | 0.58467605 |
| 108 | CAMK4 | 0.57958840 |
| 109 | SRPK1 | 0.57940888 |
| 110 | MAPK11 | 0.57734297 |
| 111 | CDK2 | 0.57671986 |
| 112 | AURKA | 0.57569118 |
| 113 | MAPK12 | 0.57497433 |
| 114 | PDPK1 | 0.55578886 |
| 115 | PAK1 | 0.54450563 |
| 116 | LMTK2 | 0.54264863 |
| 117 | MARK2 | 0.52206888 |
| 118 | DYRK1B | 0.51807386 |
| 119 | HIPK2 | 0.51520114 |
| 120 | CAMKK1 | 0.51375615 |
| 121 | RPS6KA2 | 0.51373123 |
| 122 | CSNK2A2 | 0.51156488 |
| 123 | LCK | 0.50815765 |
| 124 | SIK3 | 0.48511059 |
| 125 | PDK1 | 0.48498291 |
| 126 | KSR2 | 0.47689257 |
| 127 | PLK3 | 0.45839775 |
| 128 | TXK | 0.43856101 |
| 129 | MAP2K2 | 0.43567788 |
| 130 | IRAK4 | 0.42279397 |
| 131 | DAPK3 | 0.39951641 |
| 132 | CLK1 | 0.39085367 |
| 133 | ILK | 0.38709342 |
| 134 | HCK | 0.38093871 |
| 135 | BMX | 0.37255149 |
| 136 | MAPK4 | 0.37151128 |
| 137 | CSNK2A1 | 0.36947735 |
| 138 | CDK6 | 0.36128547 |
| 139 | MKNK1 | 0.35933439 |
| 140 | PRKG2 | 0.33245851 |
| 141 | MAP3K7 | 0.33223048 |
| 142 | JAK1 | 0.31427800 |
| 143 | RAF1 | 0.30832521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.70239161 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.45564403 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.34048386 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.01550327 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.98003234 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.94317540 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.81413973 |
| 8 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.81158583 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.50579930 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.39601642 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.33496528 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.33119578 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.30374388 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.30342306 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15175438 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10084816 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.98104192 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97488224 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.96145548 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.92811109 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78604224 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.69016389 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68734836 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.65916809 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.64576219 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.58333698 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55087480 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52133002 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51487906 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49413735 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48264491 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42952747 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35917946 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34499948 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32567617 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32094485 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27861888 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27144833 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24466012 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22607689 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21507813 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16056055 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08897685 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08576246 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08484203 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07652881 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06819155 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06014843 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.05821805 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01383257 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01064164 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00710356 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00045428 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.99773960 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.98513910 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.96402065 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95831407 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95407861 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94944718 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94657987 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94065857 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93727615 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.87480480 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86740277 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85438358 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85344831 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83250489 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82921517 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82797088 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81599937 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80663713 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.80560930 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.77504758 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.76785862 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76607034 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73858877 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72048127 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69755965 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69297024 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.68494216 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67901831 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65749843 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65701977 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.63908367 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61725839 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59898784 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59848412 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59352011 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59127827 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59080632 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58898563 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55797740 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54530823 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53744610 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53606838 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.52903764 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.52758818 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52628463 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52373175 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50685556 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49195438 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48131412 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47977678 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46828849 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.46651569 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44558019 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44412010 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43824513 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.42740322 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42564060 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42560223 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42389533 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41982626 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.41661927 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40856295 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.39323270 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37739671 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.36269979 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36020745 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35597785 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.35544330 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35091694 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34675123 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.34613695 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34330294 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.34279146 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32542246 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32225405 |
| 129 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31669399 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30868784 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30741585 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.28635459 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26235748 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24663609 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21856041 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20499101 |
| 137 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20069134 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19087815 |

